Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes

Completed · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The purpose of this study is to evaluate the effect of medically-tailored meal delivery (10 meals per week for 3 months) on glycemic control in diabetic patients.

Key facts

Study ID

NCT04523155

Run by

Mayo Clinic

People needed

34

Starts

2020-08-24

Expected to finish

2021-06-04

Last updated by the study team

2021-07-12

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult men and women with non-insulin dependent diabetes.
• Ages 25 to 75 years.
• Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%.
• Stabilized patients on oral hypoglycemic agents for one month or longer prior to starting the study and a hemoglobin A1C between 7.5% - 13%.

You may not qualify if…

• Insulin use.
• Substance abuse.
• Any documented medical problem that would inhibit full participation in the study.
• BMI less than 25 or great than 40.
• Vegans or Vegetarians
• Individuals with food allergies.
• Individuals currently on a commercial weight loss or diet program.

Where it is running

• Mayo Clinic in Florida — Jacksonville, Florida, United States
• Mayo Clinic — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.